ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.

Esraa M Zakaria et al.PubMed ↗Publisher ↗

No numbers read from the abstract.